Publications

cemka > Publications

Sort publications on year

  • Pharmaco - Epidemiology

    Treatment Patterns and Survival in Patients with Intermediate, Advanced, or Terminal Stage of Hepatocellular Carcinoma in France over the Period 2015-2017: A Real-Life Study

    BLANC J-F, LAURENDEAU C, DE ZELICOURT M, DHAOUI M, KELKOULI N, FAGNANI F, MATHURIN P.

    GastroHep ; 2023; Article ID 5800168, 12 pages

  • Biometry and database analysis

    Health status and comorbidities of adult patients with phenylketonuria (PKU) in France with a focus on early-diagnosed patients – A nationwide study of health insurance claims data

    CHARRIERE S, MAILLOT F, BOUEE S, DOUILLARD C, JACOB C, MAREN SCHNEIDER K, THEIL J, ARNOUX J-B.

    Molecular Genetics and Metabolism ; 2023;139(3):107625

  • Pharmaco - Epidemiology

    Point-of-Care Testing for SARS-CoV-2 : A Prospective Study in a Primary Health Centre

    DANIELS R, COTTIN J, KHANAFER N

    Diagnostics ; 2023;13(11):1888

  • Public Health and Epidemiology

    Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing.

    MARCHADIER A, BEZANNIER L,  BARRE-PIERREL S, MANCEAU A,  ABADIE A, DETOURNAY B.

    J Med Screen ; 2023;9691413231158932

  • Pharmaco - Epidemiology

    Asthma burden according to treatment steps in the French population-based cohort CONSTANCES.

    ROCHE N, NADIF R, FABRY-VENDRAND C, PILLOT L, THABUT G, TEISSIER C, BOUEE S, GOLDBERG M, ZINS M.

    Respir Med ; 2023;206:107057

  • Biometry and database analysis

    Treatment patterns, risk factors and outcomes for patients with newly diagnosed hepatocellular carcinoma in France: A retrospective database analysis

    MATHURIN P, DE ZELICOURT M, LAURENDEAU C, DHAOUI M, KELKOULI N, BLANC J-F.

    Clin Res Hepatol Gastroenterol ; 2023;47(5):102124

  • Pharmaco - Epidemiology

    Medico-economic comparison of two anticoagulant treatment strategies: Vitamin K antagonists vs. direct oral anticoagulants in older adults in nursing homes in France. The “MIKADO” study

    PISICA-DONOSE G, PICCOLI M, GENET B, BOUEE S, BERECHET S, BERECHET I, DACASA CORTES A, ATSAMENA S, BAYLE C, BADESCU M, CATELAIN F, KERMECHE L, MERLIER I, RAKOTONIARY S, SAVIN V, VIDAL A, VIDAL J-S, HANON O.

    PLoS One  ; 2023;18(4):e0283604

  • Public Health and Epidemiology

    Organisational Impact of a Remote Patient Monitoring System for Heart Failure Management: The Experience of 29 Cardiology Departments in France.

    ALAMI S, COUROUVE L, LANCMAN G, GOMIS P, AL-HAMOUD G, LAURELLI C, PASCHE H, CHATELLIER G, MERCIER G, ROUBILLE F, DELVAL C, DURAND-ZALESKI I.

    Int J Environ Res Public Health ; 2023;20(5):4366

  • Pharmaco - Epidemiology

    The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus.

    DE SEZE J, SUCHET L, MEKIES C, MANCHON E, LABAUGE P, GUENNOC AM, DEFER G, CLAVELOU P, CASTELNOVO G, BOURRE B, BENSA-KOSCHER C, AL KHEDR A, LE MAO J, VILLEMUR L, BOUEE S, LUCIANI L, VERMERSCH P.

    Neurol Ther ; 2023;12(2):351-369

  • Others

    Données et preuves en vie réelle dans l’évaluation des technologies de santé : dans quels cas sont-elles complémentaires,substitutives, ou les seules sources de données par rapport aux essais cliniques ?

    DE POUVOURVILLE G, ARMOIRY X, LAVOREL A, BILBAULT P, MAUGENDRE P, BENSIMON L, BEZIZ D, BLIN P, BORGET I, BOUEE S, COLLIGNON C, DERVAUX B, DURAND-ZALESKI I, JULIEN M, DE LEOTOING L, MAJED L, MARTELLI N, SEJOURNE T, VIPREY M.

    Therapie ; 2023;78(1):66-80

  • Pharmaco - Epidemiology

    Lipid-lowering efficacy and safety of alirocumab in a real-life setting in France: insights from the ODYSSEY APPRISE study.

    HENRY P, CARIOU B, FARNIER M, LAKHDARI SL, DETOURNAY B.

    Arch Cardiovasc Dis ; 2023;116(1):3-8

  • Pharmaco-Economics

    Influence of geographic access and socioeconomic characteristics on breast cancer outcomes: A systematic review.

    CONTI B, BOCHATON A, CHARREIRE H, KITZIS-BONSANG H, DESPRÈS C, BAFFERT S, NGÔ C.

    PLoS One ; 2022;17(7):e0271319

  • Pharmaco-Economics

    Important decrease in hospitalizations for acute diabetes events following FreeStyle Libre® system initiation in people with type 2 diabetes on basal insulin therapy in France.

    GUERCI B, ROUSSEL R, LEVRAT-GUILLEN F, DETOURNAY B, VICAUT E, DE POUVOURVILLE G, EMERY C, RIVELINE JP.

    Diabetes Technol Ther   ; 2023;25(1):20-30

  • Pharmaco-Economics

    Perioperative time and economic impact of an intracameral combination of mydriatics and anaesthetics in routine cataract surgery.

    ZALUSKI S, AMZALLAG T, BOUCHUT P, PINSARD L, THERON JP, TELLOUCK-MORINCOMME J, BAFFERT S.

    Eur J Ophthalmol ; 2023;33(1):239-246

  • Pharmaco-Economics

    A telemonitoring programme in patients with heart failure in France: a cost‑utility analysis

    CAILLON M, SABATIER R, LEGALLOIS D, COUROUVE L, DONIO V, BOUDEVIN F, DE CHALUS T, HAUCHARD K, BELIN A, MILLIEZ P.

    BMC Cardiovascular Disorders ; 2022;22(1):441